Author:
Murphy Brittany L.,Boughey Judy C.
Publisher
Springer Science and Business Media LLC
Reference5 articles.
1. Boughey JC, Suman VJ, Mittendorf EA, et al. Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial. JAMA 2013;310(14):1455–61.
2. Murphy BL, L Hoskin T, Heins CDN, Habermann EB, Boughey JC. Preoperative prediction of node-negative disease after neoadjuvant chemotherapy in patients presenting with node-negative or node-positive breast cancer. Ann Surg Oncol. 2017;24(9):2518–25.
3. Zakaria S, Degnim AC, Kleer CG et al. Sentinel lymph node biopsy for breast cancer: how many nodes are enough? J Surg Oncol. 2007;96(7):554–9.
4. Murphy BL, Jakub JW, Asaad M, et al. Sentinel lymph node removal after neoadjuvant chemotherapy in clinically node-negative patients: when to stop? Ann Surg Oncol. 2020. https://doi.org/10.1245/s10434-020-08816-9.
5. American College of Surgeons Clinical Research Program, Alliance for Clinical Trials in Oncology, Heidi D. Nelson MD, MPH, Kelly K. Hunt MD. Operative Standards for Cancer Surgery. Volume I: Breast, Lung, Pancreas, Colon. Philadelphia: Wolters Kluwer, 2015.